Acne, melasma, rosacea, pigmentation, hair loss, and dermatologic conditions.
Why oral minoxidil at low dose has become a workhorse for female pattern hair loss, how Korean dermatology practices approach diagnosis and combination therapy, and what the evidence supports.
Why some patients on semaglutide or tirzepatide notice hair shedding, what pharmacovigilance and review data show, the likely telogen effluvium mechanism, and how it is managed.
Why adult-onset acne in women is often hormonally driven, how it differs from adolescent acne, and what the evidence supports for combined oral contraceptives, spironolactone, and topical therapy.
Evidence for FDA-approved hydroquinone + tretinoin + fluocinolone for melasma — efficacy vs monotherapy, adverse effects, and adjunctive options.